Pharma

MilliporeSigma to Acquire HUB Organoids Holding B.V., Advancing Next Generation Biology Portfolio

December 18, 2024

Tasca Therapeutics Launches with $52 Million Series A Financing

December 10, 2024

UnitedHealthcare CEO Shot Dead in New York City

December 5, 2024

THIS WEEK'S STORIES

MAIA Biotechnology Granted FDA Rare Pediatric Disease Designation for THIO as a Treatment for Pediatric High-Grade Gliomas

December 16, 2024

Iron Path Capital Welcomes Ian Thomas as Managing Director – Head of Business Development

December 18, 2024

Headlamp Health Appoints Veteran Healthcare Technology Leader as Chief Executive Officer and Board Member

December 18, 2024

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

MAIA Biotechnology Granted FDA Rare Pediatric Disease Designation for THIO as a Treatment for Pediatric High-Grade Gliomas

Sudo Biosciences Announces First Participants Dosed in Phase 1 Trial of Brain-Penetrant Allosteric TYK2 Inhibitor SUDO-550

Precision BioSciences Highlights Preclinical Data and Outlines Design of First-in-Human Clinical Trial for PBGENE-HBV for Treatment of Chronic Hepatitis B

Aptar Pharma Enters into Exclusive Agreement with Cambridge Healthcare Innovations to Commercialize the Quattrii Dry Powder Inhaler Platform

Scripps Research Advances Breakthrough Regenerative Medicines to Reverse Aging-Related Diseases

Most Read

Iron Path Capital Welcomes Ian Thomas as Managing Director – Head of Business Development

CardioFocus Announces First Patients Treated with OptiShot™ Pulsed Field Ablation System

MilliporeSigma to Acquire HUB Organoids Holding B.V., Advancing Next Generation Biology Portfolio

Fresenius Kabi Launches Epinephrine Injection, USP Expanding U.S. Pharma Portfolio

EDITOR PICKS

MilliporeSigma to Acquire HUB Organoids Holding B.V., Advancing Next Generation Biology Portfolio

Tasca Therapeutics Launches with $52 Million Series A Financing

UnitedHealthcare CEO Shot Dead in New York City

THIS WEEK'S STORIES

MAIA Biotechnology Granted FDA Rare Pediatric Disease Designation for THIO as a Treatment for Pediatric High-Grade Gliomas

Iron Path Capital Welcomes Ian Thomas as Managing Director – Head of Business Development

Headlamp Health Appoints Veteran Healthcare Technology Leader as Chief Executive Officer and Board Member

POPULAR CATEGORY

ABOUT US

FOLLOW US